Skip to main content
Clinical Trials/ACTRN12606000019505
ACTRN12606000019505
Recruiting
Phase 3

A Study to Evaluate the Impact of Patient Self Management on Oral Anticoagulation of Patients with Mechanical Heart Valve Replacement and/or Chronic Atrial Fibrillation

Royal Prince Alfred Hospital Cardiothoracic Department0 sites300 target enrollmentJanuary 13, 2006

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Oral Anticoagulation
Sponsor
Royal Prince Alfred Hospital Cardiothoracic Department
Enrollment
300
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 13, 2006
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Royal Prince Alfred Hospital Cardiothoracic Department

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient has one or more mechanical valve(s) or chronic (greater than 3 months) Atrial Fibrillation. 2\. Patient has been taking Warfarin/Coumadin for at least 3 months. 3\. Patients INR has been in therapeutic range for \> 2 weeks. 4\. Patient has had no more than a \<2mg change in their warfarin dose in the last four weeks. 5\. Patient speaks English. 6\. Patient can read English. 7\. Patient has access to a telephone.

Exclusion Criteria

  • 1\. Patient is known to have a coagulation disorder2\. Patient has known underlying liver disease3\. Patient has a drug or alcohol addiction that is likely to limit compliance with the study routine.4\. Patient has a visual deficit likely to limit compliance.5\. Patient failed the mini mental test (AMT)6\. Patient has any other condition that is likely to limit compliance (e.g. tremor or tactile dysfunction).

Outcomes

Primary Outcomes

Not specified

Similar Trials